Product correctly added to cart.

discount label
Descyclopropyl Lenvatinib
View 3D

TRC logo

Descyclopropyl Lenvatinib

CAS: 417719-51-8

Ref. TR-D288150

10mg
324.00 €
50mg
1,357.00 €
100mg
2,079.00 €
Estimated delivery in United States, on Tuesday 21 Jan 2025

Product Information

Name:
Descyclopropyl Lenvatinib
Controlled Product
Synonyms:
  • 4-[4-[(Aminocarbonyl)amino]-3-chlorophenoxy]-7-methoxy-6-quinolinecarboxamide
  • Lenvatinib M1
Description:

Applications Descyclopropyl Lenvatinib is a metabolite of Lenvatinib (L329400) which is an orally active inhibitor of multiple receptor tyrosine kinases including VEGF, FGF and SCF receptors.
References Matsui, J., et al.: Clin. Cancer Res., 14, 5459 (2008); Gild, M., et al.: Nature Rev. Endocrinol., 7, 617 (2011)

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
TRC
Long term storage:
Notes:

Chemical properties

Molecular weight:
386.79
Formula:
C18H15ClN4O4
Color/Form:
Red Brown
InChI:
InChI=1S/C18H15ClN4O4/c1-26-16-8-14-10(7-11(16)17(20)24)15(4-5-22-14)27-9-2-3-13(12(19)6-9)23-18(21)25/h2-8H,1H3,(H2,20,24)(H3,21,23,25)
InChI key:
InChIKey=LBVQYBKTDGVCTR-UHFFFAOYSA-N
SMILES:
COc1cc2nccc(Oc3ccc(NC(N)=O)c(Cl)c3)c2cc1C(N)=O
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: TR-D288150 Descyclopropyl Lenvatinib

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".